July 30, 2025

KAIST enables on-site disease diagnosis in just 3 minutes…nanozyme reaction selectivity improved 38-fold

July 30, 2025 / Research update / InnovateMed Author / disease diagnosis

Peer-Reviewed Publication The Korea Advanced Institute of Science and Technology (KAIST) image: <(From Left) Professor Jinwoo Lee, Ph.D candidate Seonhye Park and Ph.D candidate Daeeun Choi from Chemical & Biomolecular Engineering> view moreCredit: KAIST To enable early diagnosis of acute illnesses and effective management of chronic conditions, point-of-care testing (POCT) technology—diagnostics conducted near the patient—is drawing global attention. […]

KAIST enables on-site disease diagnosis in just 3 minutes…nanozyme reaction selectivity improved 38-fold Read More »

Better sleep, better life — KAIST’s sleep algorithm comes to Samsung Galaxy watches

July 30, 2025 / Clinical Practice / InnovateMed Author / better sleep

The personalized sleep guide, created by Professor Jae Kyoung Kim’s research team at KAIST and the Institute for Basic Science (IBS), doesn’t just tell you how long you slept. It actually recommends the best time for you to go to bed — helping you b Business Announcement The Korea Advanced Institute of Science and Technology

Better sleep, better life — KAIST’s sleep algorithm comes to Samsung Galaxy watches Read More »

Mucosal adenovirus vaccine Ad5-XBB.1.5 boosting elicits nasal IgA and transiently prevents JN.1 wave infection for less than 6 months in real-world settings

July 30, 2025 / Research update / InnovateMed Author / mucosal adenovirus vaccine

Peer-Reviewed Publication Tsinghua University Press image: Mucosal adenovirus vaccine Ad5-XBB.1.5 boosting elicits nasal IgA and transiently prevents JN.1 wave infection for less than 6 months in real-world settings view more Credit: Jincun Zhao, The First Affiliated Hospital of Guangzhou Medical University As the SARS-CoV-2 viruses continue to evolve, mucosal immunity, particularly secretory immunoglobulin A (sIgA), has

Mucosal adenovirus vaccine Ad5-XBB.1.5 boosting elicits nasal IgA and transiently prevents JN.1 wave infection for less than 6 months in real-world settings Read More »

“Breakthrough in progeria therapy: RNA scissors precisely target and remove mutant gene”

July 30, 2025 / Research update / InnovateMed Author / mutant gene, progeria therapy

For the first time globally, researchers have developed an RNA-based therapy that precisely targets and removes progerin—the root cause of progeria Peer-Reviewed Publication National Research Council of Science & Technology Mechanism of Action and Expected Benefits of RNA-Targeted Gene Therapy view moreCredit: Korea Research Institute of Bioscience and Biotechnology (KRIBB) Children who develop deep wrinkles,

“Breakthrough in progeria therapy: RNA scissors precisely target and remove mutant gene” Read More »

Uncovering how a molecule responsible for immune “brakes” directs skin defenses

July 30, 2025 / Research update / InnovateMed Author / immune breaks

Peer-Reviewed Publication Weill Cornell Medicine Weill Cornell Medicine researchers have discovered that PD-1—a molecule best known for putting the brakes on immune cells—also plays a critical role in helping T cells become long-term immune defenders in the skin. Early during infection, PD-1 acts like a steering wheel, guiding T cells to become protective resident memory

Uncovering how a molecule responsible for immune “brakes” directs skin defenses Read More »

KAIST enables on-site disease diagnosis in just 3 minutes…nanozyme reaction selectivity improved 38-fold

Better sleep, better life — KAIST’s sleep algorithm comes to Samsung Galaxy watches

Mucosal adenovirus vaccine Ad5-XBB.1.5 boosting elicits nasal IgA and transiently prevents JN.1 wave infection for less than 6 months in real-world settings

“Breakthrough in progeria therapy: RNA scissors precisely target and remove mutant gene”

Uncovering how a molecule responsible for immune “brakes” directs skin defenses

Need Help?

We are here to help.